Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	62.82	23.35	14.34
Graham Fair Price	-55.97	11721.58	26623.53
PEG	13891.21	-0.09	< 0.005
Price/Book	1.32	0.40	0.40
Price/Cash Flow	-34.98	14.20	-21.84
Prices/Earnings	418.80	7.50	1.45
Price/Sales	11.41	0.75	0.68
Price/FCF	-34.98	14.20	-21.84
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-26.71	0.17	0.23
Operating Margin	-47.12	0.06	0.11
ROA	-80.99	< 0.005	0.03
ROE	0.07	0.01	-80.47
ROIC	0.04	0.01	-60.38
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	0.02	37.68
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.27	-0.52	-77.06
EPS QOQ	21.72	-0.81	-96.29
FCF QOQ	-24.13	2.55	-89.42
Revenue QOQ	0.21	-0.09	-54.38
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	31.18	40.25	29.07
Days Sales Outstanding (DSO)	61.77	64.07	3.73
Inventory Turnover	2.89	2.24	-22.52
Debt/Capitalization	0.46	0.47	1.60
Quick Ratio	0.48	0.49	1.87
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	21426.37	21346.38	-0.37
Cash	1265.64	2417.98	91.05
Capex	-1607.81	-570.98	64.49
Free Cash Flow	-389.19	604.16	55.24
Revenue	12557.35	11377.55	-9.40
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.67	0.70	4.56
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.68	15.54	60.66
Naive Interpretation	Member

06 - Financial Health · Bad

Rating